These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9790103)

  • 1. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
    Basarab T; Orchard G; Russell-Jones R
    Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
    Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
    Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
    Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
    Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms.
    Kirchmann TT; Prieto VG; Smoller BR
    J Cutan Pathol; 1995 Oct; 22(5):422-6. PubMed ID: 8594074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
    Poniecka AW; Alexis JB
    Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
    Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
    J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peanut agglutinin immunohistochemistry of basal cell carcinoma.
    Vigneswaran N; Haneke E; Peters KP
    J Cutan Pathol; 1987 Jun; 14(3):147-53. PubMed ID: 3301928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining for CD34 to determine trichoepithelioma.
    Bryant D; Penneys NS
    Arch Dermatol; 1995 May; 131(5):616-7. PubMed ID: 7537953
    [No Abstract]   [Full Text] [Related]  

  • 16. Basal cell carcinoma in association with multiple trichoepitheliomas.
    Misago N; Narisawa Y
    Dermatology; 2001; 202(3):261-5. PubMed ID: 11385237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichoepithelioma: a 19-year clinicopathologic re-evaluation.
    Bettencourt MS; Prieto VG; Shea CR
    J Cutan Pathol; 1999 Sep; 26(8):398-404. PubMed ID: 10551412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p27kip1 in basal cell carcinomas and trichoepitheliomas.
    Cesinaro AM; Migaldi M; Corrado S; Maiorana A
    Am J Dermatopathol; 2002 Aug; 24(4):313-8. PubMed ID: 12142610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinomas arising within multiple trichoepitheliomas.
    Pincus LB; McCalmont TH; Neuhaus IM; Kasper R; Oh DH
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():59-64. PubMed ID: 18544067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.